Becton Dickinson (BDX) Net Income towards Common Stockholders (2009 - 2026)
Becton Dickinson (BDX) reported Net Income towards Common Stockholders of -$274.0 million for Q1 2026, down 282.67% year-over-year from $150.0 million in Q1 2025, and down 171.73% quarter-over-quarter from $382.0 million in Q4 2025.
Becton Dickinson (BDX) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Net Income towards Common Stockholders data on file, last reported at -$274.0 million in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$274.0 million, down 282.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 12.31% YoY), and the FY2025 annual result was $1.7 billion, down 1.58% from the prior year.
- Net Income towards Common Stockholders slipped to -$274.0 million in Q1 2026 per BDX's latest filing, from $382.0 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $574.0 million in Q2 2025 and troughed at -$274.0 million in Q1 2026.
- A 5-year average of $340.6 million and a median of $392.0 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2024 and 2026: Net Income towards Common Stockholders surged 270.37% in 2024, then tumbled 282.67% in 2026.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $486.0 million in 2022, then sank by 42.18% to $281.0 million in 2023, then grew by 7.83% to $303.0 million in 2024, then increased by 26.07% to $382.0 million in 2025, then tumbled by 171.73% to -$274.0 million in 2026.
- Business Quant data shows BDX's Net Income towards Common Stockholders at -$274.0 million in Q1 2026, $382.0 million in Q4 2025, and $493.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 72.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -274.00 Mn |
| Dec 31, 2025 | 382.00 Mn |
| Sep 30, 2025 | 493.00 Mn |
| Jun 30, 2025 | 574.00 Mn |
| Mar 31, 2025 | 150.00 Mn |
| Dec 31, 2024 | 303.00 Mn |
| Sep 30, 2024 | 400.00 Mn |
| Jun 30, 2024 | 487.00 Mn |
| Mar 31, 2024 | 537.00 Mn |
| Dec 31, 2023 | 281.00 Mn |
| Sep 30, 2023 | 108.00 Mn |
| Jun 30, 2023 | 392.00 Mn |
| Mar 31, 2023 | 438.00 Mn |
| Dec 31, 2022 | 486.00 Mn |
| Sep 30, 2022 | 265.00 Mn |
| Jun 30, 2022 | 338.00 Mn |
| Mar 31, 2022 | 431.00 Mn |
| Dec 31, 2021 | 655.00 Mn |
| Sep 30, 2021 | 242.00 Mn |
| Jun 30, 2021 | 502.00 Mn |